Evaluation of endometrial changes and p53 expression in tamoxifen treated women: comparison of various methods.
Artigo
em Inglês
| IMSEAR
| ID: sea-46437
ABSTRACT
OBJECTIVE:
To compare transvaginal sonography (TVS), sonohysterography (SHG), hysteroscopy and endometrial aspiration (EA) and p53 expression in assessing endometrial abnormalities in women on tamoxifen.METHODS:
In a cross sectional study of 50 pre- and post-menopausal women receiving tamoxifen for > 2 years, all participants underwent TVS and EA. Those with endometrial thickness > 4 mm on TVS underwent hysteroscopy and SHG. Serum p53 antibody and p53 immunohistochemistry were tested in all women.RESULTS:
The sensitivity and specificity when compared with histopathology as the reference standard were as follows TVS 100% and 33.3%, SHG 85.7% and 50%, hysteroscopy 92.8% and 80.8%, serum p53 50% and 83.3%, and p53 immunohistochemistry 57.1% and 61.1%. Prevalence of endometrial abnormalities was not significantly different in asymptomatic and symptomatic women.CONCLUSION:
Tamoxifen-users require routine testing for endometrial evaluation. TVS followed by hysteroscopy and biopsy is an effective option. p53 expression correlates with histological abnormalities.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Tamoxifeno
/
Neoplasias da Mama
/
Idoso
/
Feminino
/
Humanos
/
Histeroscopia
/
Estudos Transversais
/
Antineoplásicos Hormonais
/
Adulto
/
Endométrio
Tipo de estudo:
Estudos de avaliação
/
Estudo observacional
/
Estudo de prevalência
/
Fatores de risco
Idioma:
Inglês
Ano de publicação:
2006
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS